First artificial intelligence tool to help analyse liver biopsy scans
EMA qualifies first artificial intelligence tool to help analyse liver biopsy scans

Tool is an example of integrating AI in clinical trials

Read about AI tool
Network strategy to 2028
EU medicines agencies’ network strategy to 2028

Seizing opportunities in a changing medicines landscape

Read strategy
First vaccine against epizootic haemorrhagic disease in cattle
First vaccine against epizootic haemorrhagic disease in cattle

CVMP recommends Hepizovac for approval

Read news
EMA management board
Management Board: highlights of March 2025 meeting

EMA annual report 2024 and network strategy to 2028 adopted

Read highlights
Image showing pills and a magnifying glass
Safety committee meeting: March 2025 highlights

PRAC carried out its responsibilities for managing risks associated with medicine use

Read highlights
Cell therapy
Authorities warn against risks of unregulated Advanced Therapies Medicinal Products (ATMPs)

Patients invited to report suspicious offers

Learn more about unregulated ATMPs
Woman in front of a computer, typing on a keyboard
EU launches new clinical trial map

Patients can now locate and enrol in trials in their area

Learn about trial map
Icon Magnify Glass

Find medicine

Find information on centrally authorised medicines
Icon Megaphone

What's new

Find all new and updated information published on our website in one place
icon speech question answer

FAQs

Find answers to the most frequent asked questions we receive

Latest news

SEE ALL NEWS

Events

Quarterly System Demo - Q1 2025
Online
European Medicines Agency, Amsterdam, the Netherlands
Live broadcast
Start date: 26 March 2025, 09:00 (CET)
End date: 26 March 2025, 11:30 (CET)
SEE ALL EVENTS
Back to top